Courtney Danielle, Conway Richard, Kavanagh John, O'Riordan Deirdre, Silke Bernard
Department of Internal Medicine, St James's Hospital, Dublin, Ireland.
Department of Rheumatology, Galway University Hospital, Galway, Ireland.
Postgrad Med J. 2014 Jun;90(1064):311-6. doi: 10.1136/postgradmedj-2013-132325. Epub 2014 Apr 2.
Troponin estimation is increasingly performed on emergency medical admissions. We report on a high-sensitivity troponin (hscTn) assay, introduced in January 2011, and its relevance to in-hospital mortality in such patients.
To evaluate the impact of hscTn results on in-hospital mortality and the value of incorporating troponin into a predictive score of in-hospital mortality.
All patients admitted as general medical emergencies between January 2011 and October 2012 were studied. Patients admitted under other admitting services including cardiology were excluded. We examined outcomes using generalised estimating equations, an extension of generalised linear models that permitted adjustment for correlated observations (readmissions). Margins statistics used adjusted predictions to test for interactions of key predictors while controlling for other variables using computations of the average marginal effect.
A total of 11 132 admission episodes were recorded. The in-hospital mortality for patients with predefined cut-offs was 1.9% when no troponin assay was requested, 5.1% when the troponin result was below the 25 ng/L 'normal' cut-off, 9.7% for a troponin result ≥25 and <50 ng/L, 14.5% for a troponin result ≥50 and <100 ng/L, 34.4% for a troponin result ≥100 and <1000 ng/L, and 58.3% for a troponin result >1000 ng/L. The OR for an in-hospital death for troponin-positive patients was 2.02 (95% CI 1.84 to 2.21); when adjusted for other mortality predictors including illness severity, the OR remained significant at 2.83 (95% CI 2.20 to 3.64). The incorporation of troponin into a multivariate logistic predictive algorithm resulted in an area under the receiver operating characteristic curve to predict an in-hospital death of 0.87 (95% CI 0.85 to 0.88).
An increase in troponin carries prognostic information in acutely ill medical patients; the extent of the risk conferred justifies incorporation of this information into predictive algorithms for hospital mortality.
急诊入院患者越来越多地进行肌钙蛋白检测。我们报告了2011年1月引入的一种高敏肌钙蛋白(hscTn)检测方法及其与此类患者院内死亡率的相关性。
评估hscTn检测结果对院内死亡率的影响以及将肌钙蛋白纳入院内死亡率预测评分的价值。
对2011年1月至2012年10月期间因一般内科急诊入院的所有患者进行研究。排除由包括心脏病学在内的其他收治科室收治的患者。我们使用广义估计方程来检查结果,广义估计方程是广义线性模型的扩展,允许对相关观察值(再入院)进行调整。边际统计使用调整后的预测来检验关键预测因素的相互作用,同时通过计算平均边际效应来控制其他变量。
共记录了11132次入院事件。当未进行肌钙蛋白检测时,预定义临界值患者的院内死亡率为1.9%;当肌钙蛋白结果低于25 ng/L的“正常”临界值时,死亡率为5.1%;肌钙蛋白结果≥25且<50 ng/L时,死亡率为9.7%;肌钙蛋白结果≥50且<100 ng/L时,死亡率为14.5%;肌钙蛋白结果≥100且<1000 ng/L时,死亡率为34.4%;肌钙蛋白结果>1000 ng/L时,死亡率为58.3%。肌钙蛋白阳性患者院内死亡的比值比为2.02(95%可信区间1.84至2.21);在对包括疾病严重程度在内的其他死亡率预测因素进行调整后,比值比仍显著为2.83(95%可信区间2.20至3.64)。将肌钙蛋白纳入多变量逻辑预测算法后,预测院内死亡的受试者工作特征曲线下面积为0.87(95%可信区间0.85至0.88)。
肌钙蛋白升高在急性病内科患者中具有预后信息;所带来的风险程度证明将此信息纳入医院死亡率预测算法是合理的。